ALIL - ETF AI Analysis
Top Page
Argent Focused Small Cap ETF (ALIL)
ALIL, the Argent Focused Small Cap ETF, has an overall rating that suggests it is a generally solid but not risk‑free option, supported by strong holdings like Eplus and RBC Bearings, which show robust financial performance, positive earnings commentary, and bullish technical trends. At the same time, positions such as Ligand Pharma and Houlihan Lokey, which face bearish technical signals and valuation concerns, likely weigh on the fund’s rating, and investors should also be mindful that several top holdings carry high or premium valuations that could add volatility.
ALIL vs. SPDR S&P 500 ETF (SPY)
- AUM
- 21.59M
- Region
- North America
- Expense Ratio
- 0.74%
- Beta
- 0.78
- Issuer
- Argent
- Inception Date
- Apr 08, 2025
- Dividend Yield
- 0.24%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
ALIL Summary
Argent Focused Small Cap ETF (ALIL) is a U.S. stock fund that focuses on smaller companies, aiming to beat the Russell 2000 small-cap index over time. It invests across many areas of the economy, including technology, industrials, health care, and finance. Some of its holdings include RBC Bearings and JFrog. Investors might consider ALIL if they want growth potential from smaller, lesser-known companies and diversification beyond large, familiar brands. However, small-cap stocks can be more volatile than larger companies, so the value of this ETF can move up and down sharply with the market.
How much will it cost me?
This ETF has an expense ratio of 0.74%, which means you’ll pay about $7.40 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed, with professionals selecting and weighting small-cap stocks rather than simply tracking an index.
What would affect this ETF?
ALIL could benefit if the U.S. economy stays healthy, supporting growth in small companies and its technology, industrial, and consumer-focused holdings, and if active stock picking adds value in a less-followed part of the market. On the downside, rising interest rates, an economic slowdown, or stress in small-cap and cyclical sectors could hurt performance, and its U.S.-only, concentrated small-cap exposure may make the fund more volatile than broad, large-cap ETFs.
ALIL Top 10 Holdings
ALIL is leaning into U.S. small-cap growth stories, with tech and industrial names setting the tone. JFrog and Liquidity Services have been rising steadily, giving the fund a helpful tailwind, while Ligand Pharma and The Chefs’ Warehouse add more momentum from health care and consumer niches. On the flip side, IES Holdings and Green Brick Partners have been lagging lately, acting like a bit of sand in the gears. Overall, the ETF is clearly U.S.-focused and tilted toward innovative, operationally intensive businesses rather than mega-cap household names.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 PLUS | Eplus | 4.01% | $866.06K | $2.34B | 11.29% | 81Outperform |
 NPO | Enpro | 4.15% | $896.32K | $6.04B | 13.10% | 64Neutral |
 CHEF | The Chefs' Warehouse | 3.13% | $675.36K | $4.39B | 62.68% | 72Outperform |
 GRBK | Green Brick Partners | 3.07% | $662.74K | $2.62B | 4.47% | 73Outperform |
 RBC | RBC Bearings | 3.29% | $710.33K | $15.71B | 7.75% | 77Outperform |
 HLI | Houlihan Lokey | 3.06% | $660.92K | $10.18B | -17.94% | 70Outperform |
 LGND | Ligand Pharma | 2.97% | $642.40K | $6.27B | 57.05% | 60Neutral |
 FROG | JFrog | 2.81% | $607.48K | $10.91B | 61.80% | 73Outperform |
 SKY | Champion Homes | 2.58% | $557.52K | $4.69B | 27.23% | 78Outperform |
 HRI | Herc Holdings | 2.63% | $568.85K | $5.69B | 7.92% | 67Neutral |
ALIL Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ALIL, the sentiment is Negative. The current price of 28.39 is below the 20-day moving average (MA) of 29.97, below the 50-day MA of 30.36, and below the 200-day MA of 30.50, indicating a bearish trend. The MACD of -0.10 indicates Negative momentum. The RSI at 45.06 is Neutral, neither overbought nor oversold. The STOCH value of 24.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ALIL.
ALIL Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| ALIL | $28.40 | $34.00(19.74% Upside) | $21.59M | 0.74% | 69Neutral |
 RUSC | $35.67 | $53.59(50.24% Upside) | $84.25M | 0.64% | 64Neutral |
 AIMS | $26.37 | $36.16(37.16% Upside) | $83.13M | 0.75% | 65Neutral |
 SYZ | $28.38 | $38.91(37.11% Upside) | $60.79M | 0.61% | 66Neutral |
 ESSC | $27.92 | $40.06(43.47% Upside) | $34.20M | 0.49% | 66Neutral |
 FTKI | $19.27 | $24.46(26.93% Upside) | $25.22M | 0.86% | 65Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ALIL | Argent Focused Small Cap ETF | 28.39 | -0.28 | -0.99% | |
| RUSC | US Small Cap Equity Active ETF | 35.67 | 5.57 | 18.52% | |
| AIMS | Acuitas Small Cap Active ETF | 26.36 | 1.18 | 4.71% | |
| SYZ | Lazard US Systematic Small Cap Equity ETF | 28.38 | 4.29 | 17.79% | |
| ESSC | Eventide Small Cap ETF | 27.92 | 3.39 | 13.83% | |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 19.27 | 2.57 | 15.37% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.